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Abstract
Purpose The diagnostic accuracy of intraoperative recurrent
laryngeal nerve (RLN) monitoring (IONM) remains contro-
versial. The aim of this study was to evaluate IONM diagnos-
tic accuracy in prognostication of postoperative nerve function
in thyroid surgery.
Methods This prospective study was conducted in 2011–
2013. Five hundred consenting patients qualified for total thy-
roidectomy with IONM (1000 nerves at risk) using NIM 3.0
Response equipment were included. Laryngoscopy was used
to evaluate and follow up RLN injury. The primary outcome
was diagnostic accuracy of IONM. The receiver operating
characteristics (ROC) were used for evaluation of IONM di-
agnostic accuracy.
Results Loss of signal (LOS) occurred in 31 cases, including 25
patients with LOS and corresponding vocal fold paresis found in
postoperative laryngoscopy (2.5 %), including 20 (2.0 %) tem-
porary and 5 (0.5 %) permanent nerve lesions. The following
diagnostic accuracy values were calculated for the criterion rec-
ommended by INMSG (V2 amplitude ≤ 100 μV): sensitivity
92.0 %, specificity 99.3 %, positive predictive value (PPV)
76.7 %, and negative predictive value (NPV) 99.8 %. The
ROC curve analysis allowed for calculation of the most optimal
criterion in prognostication of postoperative vocal fold paresis,
namely, V2 amplitude ≤ 189 μV. For this criterion, PPV was
77.4 %, while NPV was 99.9 %.
Conclusions Adherence to the standardized protocol recom-
mended by the International Neural Monitoring Study Group
allows for optimizing predictive values of IONM in prognos-
tication of postoperative RLN function. Any changes in the
cutoff values for the definition of LOS only marginally im-
prove PPV and NPV of IONM and need to be carefully
assessed in multicenter studies.
Keywords Thyroid surgery . Intraoperative
neuromonitoring . Recurrent laryngeal nerve . Prognostic
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Introduction
Stimulation techniques allow for certain identification of the
recurrent laryngeal nerve (RLN) and the external branch of the
superior laryngeal nerve [1–3]. Nevertheless, RLN identifica-
tion is often hindered due to neck anatomy altered by a large-
size goiter, advanced-stage thyroid cancer, or scarring after
previous procedures [2, 4]. In such situations, the
neuromapping technique may be of high assistance, allowing
for nerve localization prior to its visualization through repeat-
ed tissue stimulation in the surgical field [2, 4]. To date, the
value of the technique has not been unambiguously evaluated
in research studies. Neuromapping may also help in evaluat-
ing mechanisms underlying RLN injuries, which is closely
associated with its diagnostic value in prognostication of post-
operative nerve function [2]. The assessment of qualitative
(signal preservation or loss) or quantitative parameters
(change of signal amplitude and/or latency) of electromyo-
graphic recording may be the basis for intraoperative
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prognostication of nerve function in the postoperative period
[1, 3]. Although, to date, publications emphasize a high vari-
ability of predictive value of both a positive result (loss of
signal), which may be 10–90 %, and a negative result (pres-
ervation of normal signal) which may be 70–99 % [5–8], the
possibility of assessing preservation of functional nerve integ-
rity by intraoperative neuromonitoring (IONM) represents
significant progress as compared to assessing solely anatom-
ical nerve integrity [2]. The issue is particularly important in
preventing bilateral RLN injuries, being associated with the
problem of staged thyroidectomy consisting in abandoning
operating the contralateral side (or limiting the scope of con-
tralateral lobectomy) in case loss of signal (LOS) occurs dur-
ing resection of the first thyroid lobe [9–11]. Recent studies
suggest a possibly improved predictive IONM value based on
intraoperative analysis of surface electromyography recording
from vocal muscle signal and on employment of the standard-
ized IONM methodology developed by the International
Neural Monitoring Study Group (INMSG), with prognostica-
tion using intraoperative changes of signal amplitude and la-
tency time following vagal nerve stimulation after ipsilateral
thyroid lobe resection and correlating such changes with post-
operative RLN dysfunction [2, 8]. The issue is currently a
subject of numerous studies. Their results may affect the pres-
ently developed algorithm of thyroid surgery tactics
employing IONM of the RLN and allowing for performing a
meta-analysis of data originating from various centers.
The hypothesis explored in this study was that the use of
the standardized approach to IONM as proposed by the
INMSG may optimize the predictive values of this method
in prognostication of postoperative RLN function. The aim
of this study was to validate the diagnostic accuracy of
IONM in prognostication of postoperative RLN function in
thyroid surgery.
Methods
Study design and patients
This was a prospective cohort study of 500 patients (1000
RLNs at risk) who were qualified for total thyroidectomy with
IONM and were treated at the Third Department of General
Surgery, Jagiellonian University Medical College, Krakow,
Poland, in 2011–2013. The patients’ characteristics are pre-
sented in Table 1.
The inclusion criterion was planned total thyroidectomy
with IONM. The exclusion criteria were the surgeon’s deci-
sion not to use IONM during the case, preoperative vocal fold
paresis, and incomplete clinical data or follow-up information.
The primary outcome measure was diagnostic accuracy of
IONM in prognostication of postoperative RLN function after
thyroid surgery.
Flexible laryngoscopy was mandatory in all the patients
before operation and afterwards, being used to evaluate and
follow RLN injury. All the patients provided written informed
consent for the storage and use of their data. The protocol of
this study was approved by the Institutional Review Board
(KBET/76/B/2010). This study was reported in agreement
with the Standards for the Reporting of Diagnostic Accuracy
Studies (STARD) statement updated in 2015 [12].
Surgical technique
All the operations were performed under general anesthesia by
two experienced endocrine surgeons (MS, MB) with annual
volume of thyroid surgery >200 cases, each. The anesthesia
protocol included intravenous midazolam premedication; in-
duction with fentanyl, thiopental, and suxamethonium; endo-
tracheal intubation; and sevoflurane maintenance. No other
muscle relaxants were used during surgery. A standard
cervicotomy was used in all the patients. Visual identification
of RLN low in the neck (below the crossing with the inferior
thyroid artery) was facilitated by the use of the IONM system
employing the nerve mapping technique. Once the nerve was
visually identified, repeated stimulations with the IONM
monopolar probe served to trace the nerve path in the opera-
tive field and test its functional integrity during dissection. In
each patient, RLN was exposed and the branches of the supe-
rior and inferior thyroid arteries were divided close to the
thyroid capsule.
IONM technique
During this study period, the NIM® 3.0 system (Medtronic,
Jacksonville, USA) was used. The NIM® system operated
Table 1 Characteristics of patients
Patients in the study (n= 500)
RLNs at risk, no. 1000
Female/male ratio, no. 452:48
Median age (range), years 58 (18–79)
Preoperative diagnosis, no. (%)
Non-toxic multinodular goiter 326 (65.2)
Toxic multinodular goiter 64 (12.8)
Graves’ disease 21 (4.2)
Differentiated thyroid cancer 64 (12.8)
Primary thyroid surgery, no. (%) 435 (87.0)
Revision thyroidectomy, no. (%) 65 (13)
Thyroid specimen weight, mean ± SD, g 98.0 ± 50.0
Operating time, mean ± SD, min 102.5 ± 31.8
Data are numbers with percentages in parentheses unless otherwise
indicated
RLN recurrent laryngeal nerve, LOS loss of signal
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with surface electrodes integrated with an endotracheal tube
7.0–7.5 mm in diameter, which was inserted by an anesthetist
between the vocal folds under direct vision during intubation.
The standardized technique of IONMRLNs was used, includ-
ing indirect vagal response evaluation at the beginning and at
the end of surgery (IONM=L1+V1+R1+R2+V2+L2) ac-
cording to the recommendations formulated recently by the
International Intraoperative Neural Monitoring Study Group
[2]. The nerves were stimulated using a monopolar electrode
and the interrupted stimulation technique at 1 mA, 100 ms
impulse duration, and 4 Hz frequency. In case of the bifurcated
RLN nerves, the assessment included post-stimulation re-
sponse of each nerve branch. Adduction of the vocal folds
was detected by the endotracheal tube electromyography and
abduction by finger palpation of muscle contraction in the
posterior cricoarytenoid (Blaryngeal twitch^) [13].
LOS was defined as absence of electromyography (EMG)
signal following stimulation of the ipsilateral vagus nerve,
EMG signal amplitude below 100 μV following stimulation
with 1–2 mA current in dry field, lack of palpable laryngeal
twitch, or visible laryngeal movement following stimulation
of the ipsilateral vagus nerve [2]. To differentiate between true
and false LOS, the INMSG-proposed problem-solving algo-
rithm [2] was employed intraoperatively. In cases intraopera-
tively recognized as true LOS, the neuromapping technique
was used to determine the character of nerve damage (seg-
mental—type I, global—type II) and the localization of the
injury site.
IONMassessment was based on the definition byChan and
Lo [6]. The percentage of RLN dysfunctions was calculated
per number of RLNs at risk and not per number of patients.
Loss of signal after vagal stimulation following thyroid lobe
resection (V2) was classified as a positive test result prognos-
ticating ipsilateral vocal cord paresis. The test was interpreted
as true positive (TP) when laryngoscopy confirmed ipsilateral
vocal cord paresis and false positive (FP) when the mobility of
the ipsilateral vocal fold was normal. Preserved normal signal
following vagal stimulation after thyroid lobe resection (V2)
was classified as a negative result that prognosticated normal
postoperative mobility of the ipsilateral vocal fold. The test
was interpreted as true negative (TN) when laryngoscopy
demonstrated postoperative normal mobility of the ipsilateral
vocal fold and as false negative (FN) when ipsilateral vocal
fold paresis was seen postoperatively.
Perioperative management and follow-up
Flexible laryngoscopy by a throat specialist was mandatory
before surgery and on day 1 postoperatively. In patients with
RLN paresis, an additional examination was scheduled at 1, 2,
4, and 6 months after surgery or until the vocal cord function
was recovered. Vocal cord paresis for more than 6 months
after the operation was regarded as permanent palsy.
Statistical analysis
The resultant data were statistically processed using the statis-
tical software MedCalc (version 13, MedCalc Software,
Belgium). Assessment of the changeability of the investigated
parameters was presented by arithmetic means, median
values, standard deviations (SD), minimum and maximum
values (min-max), 95 % confidence interval (95 % CI), and
percentage of prevalence (%). An inter-group comparison of
particular properties was done by means of the χ2 test (non-
parametric variables) and by the univariate analysis of vari-
ance ANOVA (parametric variables). To assess the diagnostic
accuracy of IONM, the receiver operating characteristic
(ROC) curves were analyzed and the area under curve
(AUC) values were compared based on the non-parametric
method of DeLong et al. [14]. Thus, the predictive values of
the positive and negative results were calculated and the most
optimal predictive criterion was identified. The incidence of
nerve events was calculated based on the number of nerves at
risk. The significance level was accepted at p<0.05.
Results
Of 2034 patients referred for thyroid surgery during the study
interval, 337 underwent hemithyroidectomy while 1697 were
planned for total thyroidectomy and were potential candidates
for the study. One thousand one hundred and sixty-four pa-
tients did not meet the inclusion criteria, as there was no plan
for utilization of IONM during surgery, while 21 subjects
refused to participate, leaving 512 eligible patients of which
12 patients were lost to follow-up at 6 months leaving finally
500 patients (1000 nerves at risk) who were included in the
analysis. The flowchart of patients in this study is shown in
Fig. 1. There were 452 women and 48men, with a median age
at diagnosis of 58 years (range 18–79).
The clinical characteristics of the patients analyzed in this
study are shown in Table 1.
Intraoperative LOS was noted in 31 cases. Of 25 patients
with intraoperative LOS and early ipsilateral vocal fold paresis
in postoperative laryngoscopy (true positive result, TP), intra-
operative RLN neuromapping demonstrated segmental type
damage (type I) in 11 cases and global type (type II) in 14
cases. None of the patients showed interruption of anatomical
RLN continuity. Anterior RLN stimulation caudally from the
site of its entry to the larynx allowed for localizing the LOS
site in seven cases at the level of the Berry ligament and in four
cases at the level of its crossing the inferior thyroid artery. Of
25 cases (100 %) of early RLN damage, 20 (80 %) were
transient and 5 (20 %) permanent.
In 3 of 11 patients with LOS found after resection of the
initially dissected thyroid lobe, staged thyroidectomy was
done, whereas the remaining 8 patients had one-stage limited
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contralateral thyroid lobe surgery (Dunhill operation) to min-
imize the risk of bilateral vocal fold paresis.
Primary outcome analysis
Using the definition of LOS from the vagus nerve follow-
ing thyroid lobe resection recommended by INMSG (V2
amplitude <100 μV), in the described group of 500 surgi-
cal patients (1000 RLNs at risk) the authors noted 969
(96.9 %) TN, 23 (2.3 %) TP, 2 (0.2 %) FN, and 6
(0.6 %) FP results. Thus, the sensitivity of the criterion
was 92.0 % (95 % CI 74.0–99.0 %), specificity 99.3 %
(95 % CI 98.5–99.7 %), positive result predictive value
76.7 % (95 % CI 57.3–90.3 %), and negative result pre-
dictive value 99.8 % (95 % CI 99.3–100.0 %). The ROC
curve analysis allowed for calculating the most optimal
criterion in prognostication of postoperative vocal fold
paresis as the absolute value of V2 amplitude ≤189 μV,
which was characterized by the highest diagnostic accura-
cy (Fig. 2). For this criterion, positive result predictive
value was 77.4 % (95 % CI 58.5–90.6 %) and negative
result predictive value 99.9 % (95 % CI 99.0–100.0 %).
An additional analysis of the ROC curve that illustrated
relative V2 amplitude in relation to initial V1 amplitude
allowed for calculating the most optimal criterion in prog-
nostication of postoperative vocal fold paresis as a drop in
V2 amplitude below 18.4 % of initial V1 amplitude value
(or by more than 81.6 %); the criterion was characterized
by positive result predictive value of 76.6 % (95 % CI
57.7–90.0 %) and by negative result predictive value of
99.8 % (95 % CI 99.3–100.0 %). The optimal criterion of
V2 amplitude in prognostication of postoperative vocal
fold function and predictive values for selected V2 ampli-
tude criteria are shown in Table 2.
Discussion
Intraoperative RLN neuromonitoring is an increasingly more
commonly accepted method facilitating intraoperative nerve
identification and additionally providing valuable information
on nerve function, thus supplementing the standard of visual
assessment of preservation of anatomical nerve integrity [1,
2]. Current publications state that continuous neuromonitoring
may facilitate intraoperative identification of impending RLN
injury, which may affect changing the surgical technique or
tactics in order to prevent nerve damage [15–18]. For such an
option to become valid, further studies are necessary aiming at
understanding the mechanisms of RLN damage and factors
Fig. 1 Flow of patients in this
study
Fig. 2 Receiver operating characteristic (ROC) curve showing the
diagnostic accuracy of V2 amplitude of EMG following stimulation of
the ipsilateral vagus nerve after thyroid lobectomy in prognostication of
postoperative function of the ipsilateral vocal fold. Area under curve
(AUC)= 0.997 (95 % CI 0.992–1.000, p < 0.001)
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affecting the predictive value of neuromonitoring, which was
the subject of analysis in the present paper.
Using the definition of vagal LOS following thyroid lobe
resection recommended by INMSG (V2 amplitude <100 μV),
the authors noted in the presented material of 1000 RLNs at risk
PPVequal to 76.7 % and NPVequal to 99.8 %. The ROC curve
analysis allowed for calculating the optimal criterion in prognos-
tication of postoperative vocal fold paresis, which was an abso-
lute decrease of V2 amplitude V2 ≤189 μV. For this criterion,
PPVwas 77.4% andNPVwas 99.9%.An additional analysis of
the ROC curve illustrating the relative V2 amplitude value in
relation to the initial V1 amplitude value allowed for calculating
the most optimal criterion in prognostication of postoperative
vocal fold paresis as a drop in the V2 amplitude below 18.4 %
of the initial V1 amplitude value (or by more than 81.6 %), the
criterion being characterized by PPVequal to 76.6 % and NPV
equal to 99.8 %. Knowing the above predictive values, it can be
calculated that the minimum V1 amplitude value which may be
regarded a satisfactory initial value is 543.5 μV. The value is
much higher than V1 >100 μV, which was recommended by
INMSG in the 2011 guidelines [2]. In the described material,
more than 95 % of patients showed V1 amplitude above this
value (data not shown). This is why the predictive value of
neuromonitoring in the presented material was high. However,
the clinical utility of these modified criteria should be tested in a
large multicenter study before any agreement is reached regard-
ing the update of the INMSG 2011 guidelines. New publications
presented by other centers also emphasize the achievable high
prediction value of neuromonitoring employing standardized
methodology of the test (positive—approximately 75 %, and
negative—more than 99 %) [17–20]. Genther et al. analyzed
results of intraoperative EMG recordings following vagal stimu-
lation at the end of surgery (V2) in a group of 674 patients and
1000 RLNs at risk during thyroid or parathyroid surgery and
compared them to the percentage of vocal fold dysfunction in
postoperative fiberoptic tests. They noted that a decrease in V2
amplitude <200μVshowed positive result predictive value equal
to 72.4 % and negative result predictive value equal to 99.9 %
[18]. The above results are fully in accordance with the present
observations. In addition, in operations employing continuous
IONM, the techniquewhich is currently advocated by an increas-
ing number of experienced endocrine surgeons, the baseline
values of EMG amplitude and latency are calibrated automati-
cally at the beginning of surgery [15–18]. In patients inwhom the
initial baseline EMG amplitude is lower than or equal to 500 μV,
the position of the endotracheal tube should be corrected such
that maximum signal amplitudes of 500 μVor higher are obtain-
ed [18]. This issue is of paramount importance as the baseline V1
serves as a relative reference during the surgery and allows for
identification of combined events which precede an intraopera-
tive LOS. Combined events are usually defined as a 50 % or
greater decrease in the EMG amplitude together with a latency
increase of 10 % relative to baseline values [16]. Combined
events have been shown to precede an intraoperative LOS and
to normalize when the surgical manoeuver that caused stretching
or pressure on the RLN was halted [15–18]. On the other hand,
LOS is considered to be much more irreversible leading to RLN
paresis inmore than 80% of cases [15–18]. Hence, the definition
of LOS has a potential to evolve in the future as a result of
ongoing debate among members of the INMSG. Actually, the
outcomes of the present study support the need to validate in a
large multi-institutional study also other definitions of severe
LOS including decrease of V2 amplitude to less than 20 % of
the initial satisfactory V1 value in prognostication of postopera-
tive RLN function. This issue is crucial in the era of continuous
IONM. Schneider at al. reported that in patients operated on with
continuous IONM, there was no instance of permanent vocal
fold palsy in the 1314 nerves at risk, whereas four unilateral
permanent vocal fold palsies were seen in patients who had
intermittent IONM (0.4 % of 965 nerves, p=0.019). For contin-
uous IONM, 63 (82 %) of 77 combined events were reversible
during the operation. Thus, it seems reasonable to assume that
early detection of impending nerve injury in patients operated on
with continuous IONM may alert the surgeon to halt the
Table 2 Optimal




values for selected V2
amplitude criteria
Optimal criterion V2
Optimal criterion ≤189 μV
95 % CI 0–249 μV
Sensitivity, % 96.00
Specificity, % 99.28
Diagnostic accuracy for different criteria
Criterion V2 PPV, % 95 % CI NPV, % 95 % CI
0 μV 90.5 68.9–98.9 99.4 % 98.7–99.8
≤69 μV 82.6 61.2–95.0 99.4 % 98.7–99.8
≤100 μV 76.7 57.3–90.3 99.8 % 99.3–100.0
≤189 μV 77.4 58.5–90.6 99.9 % 99.4–100.0
≤249 μV 69.4 51.9–83.7 100.0 % 99.6–100.0
V2 vagal stimulation following ipsilateral lobectomy, PPV positive predictive value, NPV negative predictive value
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causative manoeuver, which then may result in milder nerve
injury and a better clinical outcome [18].
In practice, very high NPVof IONM, above 99.8 %, allows
for safe continuation of the planned operation of bilateral thy-
roidectomy in case normal neuromonitoring signal is pre-
served following the first lobe resection, practically eliminat-
ing the possibility of bilateral RLN damage. Yet, in intraoper-
ative LOS following one thyroid lobe resection, the decision is
more difficult due to a lower PPV (approximately 75 % on
average). Hence, numerous authors believe IONM to be a tool
allowing for obliterating the risk of bilateral vocal cord dam-
age providing staged thyroidectomy is planned in surgical
tactics or at least limiting the scope of contralateral lobe resec-
tion in cases of LOS on the side initially operated on [10, 11,
19–21]. In the present material, of 11 patients with LOS oc-
curring following resection of the first-excised dominant lobe,
staged thyroidectomy was decided on in three cases (two re-
current goiters, one nodular goiter), while a supplementary
resection of the second lobe was done 6 months after the
primary procedure, having achieved restored mobility of the
temporarily paretic vocal fold. In the remaining eight cases,
the procedure was continued as one-stage, including three
cases of thyroid cancer, where the contralateral lobe was also
totally resected, four cases of toxic multinodular goiter, and
one case of Graves’ disease, where the resection of the con-
tralateral lobe was limited to subtotal resection leaving ap-
proximately 2 ml of parenchyma in the area of the Berry
ligament (Dunhill procedure) to minimize the risk of bilateral
RLN damage. None of the above patients demonstrated LOS
during contralateral lobe resection. Similar results were also
recently presented by other authors. Melin et al. retrospective-
ly analyzed the results of 2546 thyroid procedures with IONM
carried out in 2008–2010 (4012 RLNs at risk) and found early
vocal fold paresis in 119 (3.0 %) patients and permanent pa-
resis as assessed at 18 months postoperatively in 15 (0.4 %)
individuals [10]. Using the criteria of intraoperative LOS de-
fined by INMSG, the authors noted FP neuromonitoring re-
sults in 0.6 % of cases and FN in 1.2 %. In the study,
neuromonitoring sensitivity was 80 %, specificity 99 %, pos-
itive result predictive value 68 %, and negative result predic-
tive value 99 %. In 98 cases, neuromonitoring LOS occurred
following resection of the first thyroid lobe; in 64 of these
patients, total thyroidectomies were planned. In 24 patients,
thyroidectomies were continued despite LOS following resec-
tion of the first lobe (total thyroidectomies—19 patients, and
subtotal—5 patients), which led to bilateral LOS and bilateral
vocal fold paresis in 4/24 (16.7 %) patients (including 1 after
Dunhill procedure). However, in the remaining 40 patients,
one-stage total thyroidectomies were abandoned following
LOS on the first operated side. In 18 of these patients, supple-
mentary resection of the remaining lobe was performed as
stage 2 (in 16 cases following resolution of unilateral vocal
fold paresis, and in 2 despite permanent unilateral vocal fold
paresis); no patient demonstrated bilateral vocal fold paresis.
In the remaining 22 patients, radical surgical treatment was
abandoned due to lack of absolute indications or lack of pa-
tient’s consent. While assessing patient satisfaction after
staged thyroidectomies, full understanding of and satisfaction
from such a management model was noted in 14/18 (77.8 %)
patients, while only 2/18 (11.1 %) patients professed lack of
understanding and satisfaction and 2/18 (11.1 %) individuals
were lost to follow-up [10]. The authors confirmed that the use
of IONM was helpful in selecting patients that might benefit
from staged thyroidectomies in order to prevent bilateral vocal
fold paresis. In the opinion of the majority of authors, such a
model is fully justified in patients with bilateral non-neoplastic
thyroid disease, although some believe it acceptable in proce-
dures performed for thyroid cancer [10, 11, 19–22]; the opin-
ion is not shared by all experts, however [23].
Interesting data were presented by Dralle et al. in the study
assessing the frequency of IONM RLN use in bilateral thy-
roidectomies in Germany in 2010, taking into consideration
the surgeon’s awareness and willingness to change the
planned surgical strategy in case of IONM loss following the
first thyroid lobe resection [11]. Of 1256 German surgical
wards, 1119 (89.1 %) were equipped with IONM sets. A total
of 595 (53.2 %) surgical wards participated in the study; an-
nually, they performed approximately 75 % of all thyroid pro-
cedures in Germany. IONM RLN was employed in 91.7–
93.5 % thyroid operations, with 73.8 % surgeons using vagal
stimulation (V2) following thyroidectomy. Almost 93.5 % of
responders declared their willingness to change the planned
scope of thyroid surgery in case of LOS following the first
lobe resection. The extent of change ranged from abandoning
contralateral resection (more commonly in benign goiter, es-
pecially without laryngeal compression) to limiting thyroidec-
tomy to subtotal resection of the contralateral lobe (Dunhill
procedure) to minimize the risk of postoperative bilateral vo-
cal fold paresis.
The decision to employ the model of staged thyroidectomy
in clinical practice requires discussing the issue with the pa-
tient prior to planned surgery [10, 11, 19]. As confirmed by
our experience and the published data, patients most often
understandingly accept such a solution, especially when qual-
ified for thyroid reoperation due to recurrent goiter when the
risk of RLN damage is higher than in primary operations [8].
Despite a prospective design, the current study has several
limitations. Not all eligible patients were included, as the em-
ployment of IONM in Poland is not reimbursed by the Polish
National Health Fund which is the main reason for using this
technique on select patients depending on the individual sur-
geon’s preferences and availability of the equipment. The oper-
ations were performed not by one, but two (MS, MB) surgeons.
However, in order to minimize the risk of any bias, all the sur-
geons involved in this study had a comparable background ex-
perience both in thyroid surgery and utilization of IONM during
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thyroidectomy. Postoperative laryngoscopy was not performed
immediately after surgery in the recovery room, but at postoper-
ative day 1, which in theorymight have led to underestimation of
the prevalence of short-lasting transient nerve injuries [24].
In the nearest future, we should expect further populariza-
tion of neuromonitoring in thyroid and parathyroid surgery,
since its cost accounts for only 5–7 % of total cost of thyroid-
ectomy and the value of this method in preventing bilateral
RLN damage—a complication being the most common cause
of claim awarding in civil lawsuits—is presently well-
documented [25, 26].
Conclusions
Adherence to the standardized protocol recommended by
INMSG allows for optimizing predictive values of intraopera-
tive neural monitoring in prognostication of postoperative RLN
function. Negative predictive value of the method equal to
99.8 % allows for safe continuation of planned bilateral thyroid
surgery in case of intact neural monitoring signal after unilateral
thyroid lobectomy. Positive predictive value of themethod equal
to 76.7 % makes it a rationale for staged planned total thyroid-
ectomy in case of LOS after unilateral thyroid lobectomy in
order to abolish the risk of bilateral vocal fold paresis. Any
changes in the cutoff values for the definition of LOS only
marginally improve the clinical benefit (PPV and NPV) of
IONM and need to be carefully assessed in multicenter studies.
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